Days Alive and Out of Hospital as an Outcome Measure in Patients Receiving Hyperacute Stroke Intervention.
Joseph DonnellyJae Beom HongLuke BoyleVivien T Y YongWilliam K DiproseJuliette MeyerDouglas CampbellPeter Alan BarberPublished in: Journal of the American Heart Association (2024)
In patients with stroke treated with reperfusion therapies, DAOH-90 shows reasonable comparability to the more established outcome measure of mRS-90. DAOH-90 can be readily obtained from administrative databases and therefore has the potential to be used in large-scale clinical trials and comparative effectiveness studies.